| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Corpus Luteum | 21 | 2010 | 87 | 3.660 |
Why?
|
| Ovarian Neoplasms | 25 | 2020 | 4541 | 2.410 |
Why?
|
| Neoplastic Stem Cells | 12 | 2018 | 1353 | 2.370 |
Why?
|
| Endometrial Neoplasms | 17 | 2017 | 1258 | 2.180 |
Why?
|
| Cyclins | 12 | 2019 | 644 | 1.640 |
Why?
|
| Uterine Neoplasms | 11 | 2018 | 1423 | 1.390 |
Why?
|
| Leiomyoma | 6 | 2018 | 668 | 1.190 |
Why?
|
| Carcinoma, Endometrioid | 4 | 2017 | 284 | 1.110 |
Why?
|
| Dinoprost | 11 | 2010 | 155 | 1.020 |
Why?
|
| Oogenesis | 3 | 2014 | 134 | 1.000 |
Why?
|
| Luteolysis | 4 | 2008 | 12 | 0.980 |
Why?
|
| Phosphoproteins | 13 | 2015 | 2626 | 0.920 |
Why?
|
| Proto-Oncogene Proteins c-kit | 4 | 2018 | 789 | 0.750 |
Why?
|
| Ovary | 7 | 2019 | 1012 | 0.720 |
Why?
|
| Progesterone | 12 | 2008 | 727 | 0.710 |
Why?
|
| Signal Transduction | 30 | 2019 | 23844 | 0.710 |
Why?
|
| Oocytes | 6 | 2012 | 1205 | 0.680 |
Why?
|
| Carrier Proteins | 12 | 2015 | 5243 | 0.680 |
Why?
|
| Apoptosis | 18 | 2020 | 10232 | 0.670 |
Why?
|
| TOR Serine-Threonine Kinases | 6 | 2017 | 2050 | 0.660 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 1 | 2017 | 133 | 0.660 |
Why?
|
| Endometriosis | 4 | 2014 | 694 | 0.660 |
Why?
|
| Cell Proliferation | 20 | 2020 | 10811 | 0.630 |
Why?
|
| Carcinosarcoma | 2 | 2014 | 119 | 0.620 |
Why?
|
| Loss of Heterozygosity | 3 | 2007 | 703 | 0.600 |
Why?
|
| Xenograft Model Antitumor Assays | 11 | 2020 | 3690 | 0.590 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 2 | 2014 | 191 | 0.590 |
Why?
|
| Vitrification | 1 | 2014 | 28 | 0.590 |
Why?
|
| Caspases | 4 | 2003 | 950 | 0.590 |
Why?
|
| Leptin | 6 | 2009 | 1581 | 0.560 |
Why?
|
| Endometrium | 8 | 2017 | 395 | 0.550 |
Why?
|
| Receptor, erbB-2 | 6 | 2020 | 2226 | 0.550 |
Why?
|
| Cystadenocarcinoma, Serous | 6 | 2020 | 434 | 0.540 |
Why?
|
| Carboplatin | 3 | 2014 | 801 | 0.540 |
Why?
|
| Mucin-1 | 1 | 2018 | 532 | 0.540 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2017 | 747 | 0.530 |
Why?
|
| Ovarian Follicle | 3 | 2019 | 222 | 0.520 |
Why?
|
| Dendritic Cells | 4 | 2014 | 2701 | 0.520 |
Why?
|
| Cryopreservation | 2 | 2014 | 587 | 0.510 |
Why?
|
| Gene Expression Regulation, Neoplastic | 15 | 2020 | 8471 | 0.490 |
Why?
|
| Glycoproteins | 6 | 2013 | 2310 | 0.480 |
Why?
|
| Teratoma | 1 | 2014 | 379 | 0.480 |
Why?
|
| Mice | 52 | 2020 | 79108 | 0.480 |
Why?
|
| Toll-Like Receptors | 2 | 2013 | 573 | 0.480 |
Why?
|
| Animals | 83 | 2020 | 168501 | 0.460 |
Why?
|
| Keratin-18 | 1 | 2010 | 41 | 0.450 |
Why?
|
| Female | 114 | 2020 | 365199 | 0.450 |
Why?
|
| Morpholines | 2 | 2014 | 535 | 0.450 |
Why?
|
| Cell Line, Tumor | 24 | 2020 | 16539 | 0.450 |
Why?
|
| Aminopyridines | 1 | 2014 | 349 | 0.440 |
Why?
|
| Receptors, Progesterone | 6 | 2016 | 1102 | 0.440 |
Why?
|
| Oligopeptides | 1 | 2017 | 1303 | 0.430 |
Why?
|
| Mice, SCID | 12 | 2020 | 2834 | 0.430 |
Why?
|
| Paclitaxel | 4 | 2015 | 1644 | 0.430 |
Why?
|
| Sphingomyelin Phosphodiesterase | 2 | 2008 | 90 | 0.420 |
Why?
|
| Disease Models, Animal | 10 | 2019 | 18133 | 0.420 |
Why?
|
| Receptors, Notch | 1 | 2014 | 754 | 0.400 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2015 | 1193 | 0.390 |
Why?
|
| DNA Repair | 1 | 2018 | 1939 | 0.380 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2014 | 879 | 0.380 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2013 | 4465 | 0.370 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2014 | 2510 | 0.370 |
Why?
|
| Gene Amplification | 6 | 2020 | 1087 | 0.360 |
Why?
|
| Antigens, CD | 5 | 2013 | 4261 | 0.360 |
Why?
|
| Granulosa Cells | 5 | 2019 | 129 | 0.360 |
Why?
|
| Peptides | 6 | 2013 | 4489 | 0.360 |
Why?
|
| Genes, erbB-1 | 1 | 2008 | 173 | 0.360 |
Why?
|
| Cell Transformation, Neoplastic | 6 | 2019 | 3020 | 0.340 |
Why?
|
| Ovarian Diseases | 1 | 2008 | 136 | 0.340 |
Why?
|
| Membrane Proteins | 4 | 2018 | 8107 | 0.340 |
Why?
|
| Hedgehog Proteins | 1 | 2011 | 739 | 0.330 |
Why?
|
| Immunohistochemistry | 14 | 2017 | 12057 | 0.330 |
Why?
|
| Epithelial Cells | 3 | 2019 | 3711 | 0.330 |
Why?
|
| CA-125 Antigen | 3 | 2018 | 284 | 0.330 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2019 | 1828 | 0.320 |
Why?
|
| Growth Inhibitors | 1 | 2007 | 394 | 0.320 |
Why?
|
| Vulvar Neoplasms | 1 | 2008 | 263 | 0.310 |
Why?
|
| Cattle | 14 | 2010 | 4021 | 0.310 |
Why?
|
| Mice, Inbred NOD | 9 | 2016 | 1912 | 0.310 |
Why?
|
| Cell Cycle | 5 | 2016 | 3051 | 0.300 |
Why?
|
| Epigenomics | 1 | 2010 | 726 | 0.300 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2006 | 143 | 0.300 |
Why?
|
| Neoplasm, Residual | 1 | 2010 | 879 | 0.300 |
Why?
|
| Cytokines | 6 | 2014 | 7006 | 0.290 |
Why?
|
| Drug Delivery Systems | 1 | 2017 | 2257 | 0.290 |
Why?
|
| Paraffin Embedding | 2 | 2017 | 323 | 0.290 |
Why?
|
| RNA, Messenger | 12 | 2014 | 13519 | 0.290 |
Why?
|
| Indoles | 4 | 2016 | 1879 | 0.290 |
Why?
|
| Neoplasm Transplantation | 6 | 2013 | 2300 | 0.280 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2008 | 593 | 0.270 |
Why?
|
| Adenocarcinoma, Clear Cell | 2 | 2005 | 232 | 0.270 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2016 | 10613 | 0.270 |
Why?
|
| Humans | 87 | 2020 | 660731 | 0.270 |
Why?
|
| Antineoplastic Agents | 9 | 2017 | 13598 | 0.270 |
Why?
|
| I-kappa B Proteins | 2 | 2001 | 248 | 0.270 |
Why?
|
| Pre-Eclampsia | 1 | 2012 | 1105 | 0.270 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2007 | 675 | 0.270 |
Why?
|
| Gene Silencing | 2 | 2007 | 1658 | 0.260 |
Why?
|
| Carcinoma | 2 | 2015 | 2340 | 0.260 |
Why?
|
| MicroRNAs | 5 | 2018 | 3487 | 0.250 |
Why?
|
| Sphingomyelins | 1 | 2002 | 105 | 0.250 |
Why?
|
| Microsatellite Repeats | 2 | 2006 | 831 | 0.250 |
Why?
|
| Carcinoma in Situ | 1 | 2008 | 805 | 0.250 |
Why?
|
| Stem Cells | 4 | 2011 | 3529 | 0.240 |
Why?
|
| Caspase 3 | 5 | 2010 | 824 | 0.240 |
Why?
|
| Fas Ligand Protein | 4 | 2010 | 244 | 0.240 |
Why?
|
| Fatty Acids, Omega-3 | 3 | 2018 | 1206 | 0.240 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2018 | 4974 | 0.230 |
Why?
|
| Repressor Proteins | 2 | 2013 | 2970 | 0.230 |
Why?
|
| Tumor Cells, Cultured | 9 | 2020 | 6741 | 0.230 |
Why?
|
| Phosphatidylinositol 3-Kinases | 5 | 2016 | 2639 | 0.230 |
Why?
|
| Pyrroles | 3 | 2013 | 1197 | 0.230 |
Why?
|
| Uterus | 5 | 2014 | 630 | 0.230 |
Why?
|
| Neovascularization, Pathologic | 5 | 2014 | 2817 | 0.230 |
Why?
|
| Tissue Adhesions | 2 | 2012 | 242 | 0.220 |
Why?
|
| Steroids | 2 | 2002 | 779 | 0.210 |
Why?
|
| Transcription Factors | 7 | 2019 | 11720 | 0.210 |
Why?
|
| Neoadjuvant Therapy | 1 | 2010 | 2188 | 0.200 |
Why?
|
| Myometrium | 2 | 2018 | 184 | 0.200 |
Why?
|
| Ceramides | 3 | 2008 | 172 | 0.200 |
Why?
|
| Adenocarcinoma | 6 | 2014 | 6377 | 0.200 |
Why?
|
| Enzyme Precursors | 1 | 1999 | 192 | 0.200 |
Why?
|
| MAP Kinase Signaling System | 3 | 2003 | 1600 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 14 | 2019 | 22892 | 0.190 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2002 | 1385 | 0.190 |
Why?
|
| Receptors, Prostaglandin | 5 | 2005 | 77 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 18 | 3 | 2007 | 269 | 0.190 |
Why?
|
| Protein Kinase Inhibitors | 5 | 2017 | 4935 | 0.180 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2013 | 4634 | 0.180 |
Why?
|
| Papillomaviridae | 2 | 2019 | 1019 | 0.180 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2019 | 2660 | 0.180 |
Why?
|
| Cell Count | 3 | 2014 | 1989 | 0.180 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 2014 | 3466 | 0.180 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2019 | 2881 | 0.180 |
Why?
|
| Interferon-gamma | 4 | 2008 | 3226 | 0.180 |
Why?
|
| Receptors, Cell Surface | 3 | 2006 | 2945 | 0.180 |
Why?
|
| Reproduction | 2 | 2012 | 667 | 0.170 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2018 | 325 | 0.170 |
Why?
|
| Clone Cells | 1 | 2020 | 1767 | 0.170 |
Why?
|
| Gene Expression | 5 | 2015 | 8071 | 0.170 |
Why?
|
| Membrane Glycoproteins | 3 | 2003 | 3857 | 0.170 |
Why?
|
| Endometrial Hyperplasia | 1 | 2017 | 77 | 0.170 |
Why?
|
| Celiac Disease | 1 | 2004 | 734 | 0.160 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2009 | 3911 | 0.160 |
Why?
|
| Endothelium, Vascular | 3 | 2008 | 4739 | 0.160 |
Why?
|
| ras Proteins | 2 | 2013 | 1140 | 0.160 |
Why?
|
| Feedback, Physiological | 1 | 2019 | 466 | 0.160 |
Why?
|
| Cystadenoma, Serous | 1 | 2016 | 95 | 0.160 |
Why?
|
| Tumor Burden | 4 | 2016 | 1901 | 0.150 |
Why?
|
| RNA, Small Interfering | 5 | 2019 | 3719 | 0.150 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2014 | 1104 | 0.150 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 3 | 2016 | 809 | 0.150 |
Why?
|
| Mice, Knockout | 9 | 2019 | 15340 | 0.150 |
Why?
|
| Mediator Complex | 1 | 2015 | 109 | 0.150 |
Why?
|
| Palliative Care | 1 | 2010 | 2981 | 0.150 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2015 | 2593 | 0.150 |
Why?
|
| Drug Screening Assays, Antitumor | 3 | 2015 | 750 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2011 | 8158 | 0.150 |
Why?
|
| Cleavage Stage, Ovum | 1 | 2014 | 49 | 0.150 |
Why?
|
| GPI-Linked Proteins | 1 | 2016 | 500 | 0.150 |
Why?
|
| Serpins | 1 | 1997 | 283 | 0.150 |
Why?
|
| Pregnancy | 12 | 2018 | 24677 | 0.140 |
Why?
|
| Cyclic S-Oxides | 1 | 2014 | 24 | 0.140 |
Why?
|
| Cells, Cultured | 12 | 2019 | 20583 | 0.140 |
Why?
|
| Transplantation, Heterologous | 3 | 2011 | 2132 | 0.140 |
Why?
|
| Stromal Cells | 2 | 2011 | 1344 | 0.140 |
Why?
|
| Thiadiazoles | 1 | 2014 | 51 | 0.140 |
Why?
|
| Cell Communication | 2 | 2020 | 1617 | 0.140 |
Why?
|
| Pituitary ACTH Hypersecretion | 1 | 2015 | 144 | 0.140 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2015 | 634 | 0.140 |
Why?
|
| Gene Expression Profiling | 6 | 2015 | 9445 | 0.140 |
Why?
|
| DNA Methylation | 4 | 2015 | 3797 | 0.140 |
Why?
|
| Adrenomedullin | 1 | 2013 | 89 | 0.140 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2013 | 85 | 0.130 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2018 | 379 | 0.130 |
Why?
|
| Mice, Transgenic | 5 | 2019 | 9932 | 0.130 |
Why?
|
| RNA, Neoplasm | 2 | 2014 | 799 | 0.130 |
Why?
|
| Extracellular Space | 1 | 2015 | 622 | 0.130 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2014 | 125 | 0.130 |
Why?
|
| Organ Specificity | 1 | 2019 | 2099 | 0.130 |
Why?
|
| Blotting, Western | 7 | 2014 | 5751 | 0.130 |
Why?
|
| Hydroxamic Acids | 1 | 2016 | 509 | 0.130 |
Why?
|
| Microsatellite Instability | 1 | 2017 | 652 | 0.130 |
Why?
|
| Chemokine CCL2 | 3 | 2008 | 665 | 0.130 |
Why?
|
| Menarche | 1 | 2015 | 473 | 0.130 |
Why?
|
| Protein-Serine-Threonine Kinases | 4 | 2019 | 3918 | 0.130 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2015 | 338 | 0.130 |
Why?
|
| Pituitary Gland | 1 | 2015 | 659 | 0.130 |
Why?
|
| Genes, MDR | 1 | 2012 | 39 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 2 | 2017 | 6754 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 324 | 0.120 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 4441 | 0.120 |
Why?
|
| Parity | 1 | 2015 | 854 | 0.120 |
Why?
|
| Capillaries | 2 | 2008 | 814 | 0.120 |
Why?
|
| Allosteric Site | 1 | 2012 | 108 | 0.120 |
Why?
|
| Veratrum Alkaloids | 1 | 2011 | 30 | 0.120 |
Why?
|
| Viral Proteins | 2 | 2019 | 1973 | 0.120 |
Why?
|
| Meiosis | 1 | 2014 | 369 | 0.120 |
Why?
|
| Neoplasm Staging | 6 | 2017 | 11045 | 0.120 |
Why?
|
| Breast Neoplasms | 2 | 2017 | 18853 | 0.120 |
Why?
|
| Genetic Fitness | 1 | 2012 | 112 | 0.120 |
Why?
|
| Antigens, Ly | 1 | 2013 | 321 | 0.120 |
Why?
|
| Blastocyst | 1 | 2014 | 387 | 0.120 |
Why?
|
| Azacitidine | 2 | 2010 | 289 | 0.120 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2017 | 1101 | 0.120 |
Why?
|
| Nucleosomes | 1 | 1995 | 468 | 0.120 |
Why?
|
| Mice, Nude | 6 | 2019 | 4032 | 0.110 |
Why?
|
| Follicular Atresia | 2 | 2008 | 7 | 0.110 |
Why?
|
| Sirolimus | 2 | 2017 | 1584 | 0.110 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2016 | 769 | 0.110 |
Why?
|
| Interleukin-6 | 3 | 2013 | 3042 | 0.110 |
Why?
|
| Cell Lineage | 2 | 2019 | 2625 | 0.110 |
Why?
|
| Theca Cells | 2 | 2008 | 16 | 0.110 |
Why?
|
| Progestins | 1 | 2012 | 263 | 0.110 |
Why?
|
| Sheep | 4 | 1999 | 1618 | 0.110 |
Why?
|
| Intestinal Neoplasms | 1 | 2013 | 318 | 0.110 |
Why?
|
| Receptor, Notch1 | 1 | 2014 | 516 | 0.110 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2012 | 206 | 0.110 |
Why?
|
| Gene Expression Regulation | 5 | 2015 | 12483 | 0.110 |
Why?
|
| beta Catenin | 3 | 2013 | 1071 | 0.110 |
Why?
|
| Blotting, Northern | 4 | 2007 | 1683 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 4 | 2019 | 6128 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2013 | 4196 | 0.110 |
Why?
|
| Receptors, Leptin | 3 | 2006 | 358 | 0.110 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2010 | 119 | 0.100 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2014 | 584 | 0.100 |
Why?
|
| Enzyme Activation | 4 | 2010 | 3946 | 0.100 |
Why?
|
| Cryoprotective Agents | 1 | 2009 | 85 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 1997 | 1369 | 0.100 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 1787 | 0.100 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2012 | 341 | 0.100 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2014 | 666 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2014 | 5168 | 0.100 |
Why?
|
| Mucin-4 | 1 | 2009 | 49 | 0.100 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2016 | 1455 | 0.100 |
Why?
|
| Scleroderma, Systemic | 1 | 2012 | 258 | 0.100 |
Why?
|
| DNA Copy Number Variations | 2 | 2020 | 1672 | 0.100 |
Why?
|
| Fertilization in Vitro | 2 | 2014 | 1152 | 0.100 |
Why?
|
| DNA | 4 | 2002 | 7321 | 0.100 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 5294 | 0.100 |
Why?
|
| Mutation | 4 | 2014 | 27832 | 0.100 |
Why?
|
| Luteal Cells | 3 | 2007 | 18 | 0.090 |
Why?
|
| Cell Cycle Proteins | 2 | 2019 | 3279 | 0.090 |
Why?
|
| Estrous Cycle | 1 | 2008 | 59 | 0.090 |
Why?
|
| Cell Separation | 2 | 2020 | 1885 | 0.090 |
Why?
|
| Homeostasis | 2 | 2019 | 3235 | 0.090 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2013 | 1106 | 0.090 |
Why?
|
| Endothelial Cells | 3 | 2008 | 3085 | 0.090 |
Why?
|
| Cisplatin | 2 | 2015 | 1688 | 0.090 |
Why?
|
| Organ Culture Techniques | 2 | 2019 | 921 | 0.090 |
Why?
|
| Oncogenes | 1 | 2013 | 1128 | 0.090 |
Why?
|
| Cell Survival | 5 | 2016 | 6284 | 0.090 |
Why?
|
| Germ Cells | 2 | 2010 | 433 | 0.090 |
Why?
|
| Immunomodulation | 1 | 2012 | 505 | 0.090 |
Why?
|
| Receptors, Interleukin-1 | 2 | 2008 | 252 | 0.090 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2007 | 191 | 0.090 |
Why?
|
| Postpartum Period | 1 | 2013 | 863 | 0.090 |
Why?
|
| Cell Death | 2 | 2010 | 1761 | 0.090 |
Why?
|
| Genes, ras | 1 | 2010 | 723 | 0.090 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2010 | 2004 | 0.090 |
Why?
|
| Pregnancy, Animal | 1 | 2008 | 147 | 0.090 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2009 | 625 | 0.090 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2008 | 267 | 0.090 |
Why?
|
| DNA Fragmentation | 3 | 2002 | 256 | 0.090 |
Why?
|
| Immunity, Cellular | 1 | 2014 | 1706 | 0.090 |
Why?
|
| Nervous System | 1 | 2010 | 563 | 0.080 |
Why?
|
| Models, Biological | 4 | 2020 | 10171 | 0.080 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2011 | 513 | 0.080 |
Why?
|
| DNA, Complementary | 3 | 2003 | 2154 | 0.080 |
Why?
|
| Trans-Activators | 3 | 2010 | 3104 | 0.080 |
Why?
|
| Embryo, Nonmammalian | 1 | 2010 | 974 | 0.080 |
Why?
|
| Ovum | 1 | 2007 | 205 | 0.080 |
Why?
|
| Receptors, Cytokine | 2 | 2004 | 267 | 0.080 |
Why?
|
| Cell Differentiation | 4 | 2019 | 11593 | 0.080 |
Why?
|
| Interferon Regulatory Factor-1 | 2 | 2008 | 67 | 0.080 |
Why?
|
| Homeodomain Proteins | 2 | 2014 | 2484 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2019 | 3400 | 0.080 |
Why?
|
| Genital Neoplasms, Female | 1 | 2010 | 458 | 0.080 |
Why?
|
| Glucocorticoids | 1 | 2015 | 2057 | 0.080 |
Why?
|
| Mesoderm | 1 | 2009 | 755 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 2 | 2015 | 2731 | 0.080 |
Why?
|
| Genes, MHC Class I | 1 | 2006 | 307 | 0.080 |
Why?
|
| Protein Isoforms | 2 | 2010 | 1719 | 0.080 |
Why?
|
| Colonic Neoplasms | 2 | 2009 | 2504 | 0.080 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2008 | 643 | 0.070 |
Why?
|
| Phenotype | 5 | 2020 | 15499 | 0.070 |
Why?
|
| Models, Animal | 1 | 2012 | 2236 | 0.070 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2008 | 335 | 0.070 |
Why?
|
| Genetic Markers | 1 | 2012 | 2764 | 0.070 |
Why?
|
| Colon | 1 | 2013 | 1772 | 0.070 |
Why?
|
| Dinucleotide Repeats | 1 | 2004 | 40 | 0.070 |
Why?
|
| Muscle, Smooth | 1 | 2009 | 1002 | 0.070 |
Why?
|
| Testicular Hormones | 1 | 2004 | 193 | 0.070 |
Why?
|
| BRCA1 Protein | 1 | 2010 | 952 | 0.070 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2013 | 1672 | 0.070 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2004 | 110 | 0.070 |
Why?
|
| Cyclin D1 | 1 | 2006 | 511 | 0.070 |
Why?
|
| Prognosis | 8 | 2012 | 28027 | 0.070 |
Why?
|
| Neurogenesis | 1 | 2010 | 787 | 0.070 |
Why?
|
| Life Style | 1 | 2015 | 3498 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 1771 | 0.070 |
Why?
|
| Dietary Fats | 1 | 2012 | 2060 | 0.070 |
Why?
|
| Databases, Genetic | 1 | 2011 | 1694 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2002 | 694 | 0.070 |
Why?
|
| Genotype | 3 | 2015 | 12841 | 0.070 |
Why?
|
| Animals, Congenic | 1 | 2003 | 26 | 0.070 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2007 | 610 | 0.070 |
Why?
|
| HeLa Cells | 1 | 2010 | 3339 | 0.070 |
Why?
|
| Zebrafish Proteins | 1 | 2010 | 1055 | 0.070 |
Why?
|
| Cloning, Molecular | 2 | 2004 | 4680 | 0.070 |
Why?
|
| DNA-Binding Proteins | 6 | 2010 | 9776 | 0.070 |
Why?
|
| Embryo Implantation | 1 | 2004 | 230 | 0.070 |
Why?
|
| Giant Cell Arteritis | 1 | 2006 | 234 | 0.070 |
Why?
|
| Spain | 1 | 2004 | 426 | 0.060 |
Why?
|
| Restriction Mapping | 1 | 2004 | 949 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2010 | 1464 | 0.060 |
Why?
|
| Aged | 10 | 2017 | 156937 | 0.060 |
Why?
|
| Caspase 8 | 1 | 2003 | 219 | 0.060 |
Why?
|
| Receptors, Estrogen | 2 | 2009 | 2087 | 0.060 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 1916 | 0.060 |
Why?
|
| Enzyme Inhibitors | 4 | 2002 | 3961 | 0.060 |
Why?
|
| Carcinoma, Papillary | 1 | 2008 | 805 | 0.060 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2013 | 2104 | 0.060 |
Why?
|
| Interleukin-8 | 1 | 2005 | 687 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2010 | 3212 | 0.060 |
Why?
|
| Colorectal Neoplasms | 2 | 2013 | 5875 | 0.060 |
Why?
|
| Wound Healing | 1 | 2013 | 2791 | 0.060 |
Why?
|
| Base Sequence | 4 | 2005 | 13741 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2015 | 5112 | 0.060 |
Why?
|
| Rabbits | 3 | 2013 | 5440 | 0.060 |
Why?
|
| Adult | 9 | 2019 | 206295 | 0.060 |
Why?
|
| Ovulation | 1 | 2002 | 194 | 0.060 |
Why?
|
| Rats | 4 | 2015 | 25424 | 0.060 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2010 | 3385 | 0.060 |
Why?
|
| Recombinant Proteins | 3 | 2019 | 7024 | 0.060 |
Why?
|
| Hydrolysis | 1 | 2002 | 752 |